Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. heart guidelines may threaten hot new cholesterol drugs
U.S. heart guidelines may threaten hot new cholesterol drugs
U.S. heart guidelines may threaten hot new cholesterol drugs
Submitted by
admin
on November 13, 2013 - 12:47pm
Source:
Yahoo/Reuters
News Tags:
cholesterol
statins
PCSK9 inhibitors
Sanofi
Regeneron
Pfizer
Amgen
Headline:
U.S. heart guidelines may threaten hot new cholesterol drugs
Do Not Allow Advertisers to Use My Personal information
